Jaguar Health is the majority shareholder of Napo Therapeutics S.p.A., an Italian corporation established by Jaguar Health in Milan, Italy, in 2021 that focuses on expanding crofelemer access in Europe (excluding Russia)... Jaguar Health is led by..
Relevance: 11.591173